Control of antiviral innate immune response by protein geranylgeranylation
UMass Chan Affiliations
Division of Infectious Diseases and Immunology, Department of MedicineDocument Type
Journal ArticlePublication Date
2019-05-29Keywords
innate immune responseantiviral
signaling protein
protein geranylgeranylation
Amino Acids, Peptides, and Proteins
Biochemical Phenomena, Metabolism, and Nutrition
Genetic Phenomena
Hemic and Immune Systems
Immunity
Immunology of Infectious Disease
Immunopathology
Virus Diseases
Viruses
Metadata
Show full item recordAbstract
The mitochondrial antiviral signaling protein (MAVS) orchestrates host antiviral innate immune response to RNA virus infection. However, how MAVS signaling is controlled to eradicate virus while preventing self-destructive inflammation remains obscure. Here, we show that protein geranylgeranylation, a posttranslational lipid modification of proteins, limits MAVS-mediated immune signaling by targeting Rho family small guanosine triphosphatase Rac1 into the mitochondria-associated endoplasmic reticulum (ER) membranes (MAMs) at the mitochondria-ER junction. Protein geranylgeranylation and subsequent palmitoylation promote Rac1 translocation into MAMs upon viral infection. MAM-localized Rac1 limits MAVS' interaction with E3 ligase Trim31 and hence inhibits MAVS ubiquitination, aggregation, and activation. Rac1 also facilitates the recruitment of caspase-8 and cFLIPL to the MAVS signalosome and the subsequent cleavage of Ripk1 that terminates MAVS signaling. Consistently, mice with myeloid deficiency of protein geranylgeranylation showed improved survival upon influenza A virus infection. Our work revealed a critical role of protein geranylgeranylation in regulating antiviral innate immune response.Source
Sci Adv. 2019 May 29;5(5):eaav7999. doi: 10.1126/sciadv.aav7999. eCollection 2019 May. Link to article on publisher's site
DOI
10.1126/sciadv.aav7999Permanent Link to this Item
http://hdl.handle.net/20.500.14038/41072PubMed ID
31149635Notes
Full author list omitted for brevity. For the full list of authors, see article.
Related Resources
Rights
Copyright © 2019. The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).Distribution License
http://creativecommons.org/licenses/by-nc/4.0/ae974a485f413a2113503eed53cd6c53
10.1126/sciadv.aav7999
Scopus Count
Collections
Except where otherwise noted, this item's license is described as Copyright © 2019. The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).